
Sanofi US
@SanofiUS
Followers
80K
Following
1K
Media
4K
Statuses
18K
We chase the miracles of science to improve people's lives. For U.S. residents only. Interactions on this page must comply with Sanofi US terms: https://t.co/D3HnfO1Ymt
Bridgewater, NJ
Joined August 2010
📢 #News: The @US_FDA has granted Orphan Drug Designation to our investigational IgG1-based, GPRC5D-targeting antibody treatment for patients with relapsed or refractory #MultipleMyeloma. Learn more ⬇️.
0
1
3
A major US real-world study published in PEDIATRICS®, an official journal of @AmerAcadPeds, shows the impact respiratory syncytial virus (#RSV) prevention had in reducing hospitalizations due to serious RSV lung infection in babies. Read our press release to learn more ⬇️.
0
0
2
Building the future of healthcare means building sustainably 🌎. Our new Morristown, NJ office will be LEED Gold certified with eco-friendly features to help shape a greener future for the planet, and our communities 🌿. Learn more ▶️ #SanofiAtMorristown
3
0
2
Congratulations to @BreakthroughT1D on the first-ever Barbie doll with type 1 diabetes! A huge step for inclusion—kids with T1D can now see themselves in Barbie and be reminded: You can be anything.
Yesterday, we were thrilled to announce a major milestone - the release of the first-ever @barbie with type 1 diabetes (T1D)! Just like advocacy, visibility matters. We’re so excited to see a Barbie with T1D out in the world, helping to represent and empower even more kids living
2
3
3
Through our newly launched Health Futures Solution Fund, we're awarding grants to 13 nonprofits across Massachusetts tackling food insecurity, housing, and more. 🌍 Learn more: #HealthyFutures #SocialImpact #CommunityPartnerships
1
1
1
Wrapping up a great week at the @ADA_DiabetesPro Conference in Chicago, IL! Thanks for another great year full of connection & collaboration with the diabetes community. Check out a few pictures of our team on the ground at #ADA2025 below.
0
0
2
The @US_FDA has granted Orphan Drug Designation to our investigational treatment for antibody-mediated rejection (AMR) in solid organ transplantation, reinforcing our commitment to addressing critical unmet needs in #Transplant medicine. Learn more ⬇️.
0
0
2
Our treatment for #BullousPemphigoid (BP) is now approved by the @US_FDA. This approval helps close a long-standing gap in care for adults with this chronic, relapsing skin condition. CC: @Regeneron.
0
1
6
At #RAD2025, we shared new phase 4 data in people with skin of color and #AtopicDermatitis. Explore the results we presented with @Regeneron ⬇️.
0
1
1
#News: At ISTH 2025, we’re presenting new data highlighting our commitment to evolving patient expectations and exploring therapeutic options for #RareBloodDisorders. Learn more about our ongoing work in immune thrombocytopenia (#ITP) and #hemophilia ⬇️.
1
1
2
#NEWS: New data at #ASCO25 published in @JCO_ASCO analyzed the potential of an investigational delivery method to administer our investigational subcutaneous #MultipleMyeloma combination therapy. Learn more ⬇️.
0
0
0
#News: The @US_FDA has granted Orphan Drug Designation to our novel, advanced, oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor for the treatment of #SickleCellDisease. Read more about the potential of this novel approach ⬇️.
0
0
0
#NEWS: First real-world comparison of respiratory syncytial virus (#RSV) immunization programs for infants to be presented at #ESPID2025. Read more ⬇️.
1
0
0
#NEWS: The @US_FDA has expanded the indication for use of our vaccination for protection against meningococcal #meningitis to infants aged six weeks and older. Read more ⬇️.
0
0
1
Unveiling #SanofiAtMorristown—our new innovative workspace in NJ. Our CEO Paul Hudson joins local leaders to open this state-of-the-art hub where scientific innovation and collaboration fuel tomorrow’s breakthroughs 🏢✨ . Learn more ⬇️.
7
1
5